DrugDashboards

Levothyroxine Sodium

Levothyroxine Sodium Anhydrous · LEVOTHYROXINE SODIUM ANHYDROUS 200 ug/5mL · Injection, Powder, Lyophilized, For Solution · Intravenous · ENDO USA, Inc.

NDC 42023-0202-01 · 1 VIAL, SINGLE-DOSE in 1 CARTON / 5 mL in 1 VIAL, SINGLE-DOSE · NDA · View full market →

The short version

6 companies supply this market — a reasonable cushion if one runs into trouble.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Medicare Part B pays (ASP+6%)$5.10per billing unit (10 MCG)HCPCS J0650 · Jul 1, 2026
  • Federal ceiling (Big4)$131.24per package of 5MLEndo USA, Inc. · Jan 1, 2026

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$211.16
Reported to Texas DSHS · 2026 annual filing · Par Health USA, LLC

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 10 MCG
$5.096
HCPCS J0650 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$2,661
20 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA202231
TE code
AP
Approval date
Jun 24, 2011
Patents / exclusivity
9 patents, 0 exclusivities
TypeNumber / codeExpires
patent9006289Oct 3, 2032
patent9006289Oct 3, 2032
patent9006289Oct 3, 2032
patent9168239Aug 29, 2032
patent9168238Aug 29, 2032
patent9168238Aug 29, 2032
patent9168239Aug 29, 2032
patent9168239Aug 29, 2032
patent9168238Aug 29, 2032

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Levothyroxine Sodium Anhydrous (Injection, Powder, Lyophilized, For Solution)

LabelerStrengthFirst seenLast seen
Fresenius Kabi USA, LLCLEVOTHYROXINE SODIUM ANHYDROUS 500 ug/5mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCLEVOTHYROXINE SODIUM ANHYDROUS 100 ug/5mLJul 15, 2026Sep 3, 2026
ENDO USA, Inc.LEVOTHYROXINE SODIUM ANHYDROUS 100 ug/5mLJul 15, 2026Sep 2, 2026
ENDO USA, Inc.LEVOTHYROXINE SODIUM ANHYDROUS 500 ug/5mLJul 15, 2026Sep 2, 2026
ENDO USA, Inc.LEVOTHYROXINE SODIUM ANHYDROUS 200 ug/5mLJul 15, 2026Sep 2, 2026
Fosun Pharma USA Inc.LEVOTHYROXINE SODIUM ANHYDROUS 100 ug/5mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCLEVOTHYROXINE SODIUM ANHYDROUS 200 ug/5mLJul 15, 2026Sep 2, 2026
MAIA Pharmaceuticals, Inc.LEVOTHYROXINE SODIUM ANHYDROUS 200 ug/5mLJul 15, 2026Sep 2, 2026
MAIA Pharmaceuticals, Inc.LEVOTHYROXINE SODIUM ANHYDROUS 100 ug/5mLJul 15, 2026Sep 2, 2026
MAIA Pharmaceuticals, Inc.LEVOTHYROXINE SODIUM ANHYDROUS 500 ug/5mLJul 15, 2026Sep 2, 2026
Onesource Specialty Pharma LimitedLEVOTHYROXINE SODIUM ANHYDROUS 100 ug/5mLJul 15, 2026Sep 2, 2026
Onesource Specialty Pharma LimitedLEVOTHYROXINE SODIUM ANHYDROUS 500 ug/5mLJul 15, 2026Sep 2, 2026
Onesource Specialty Pharma LimitedLEVOTHYROXINE SODIUM ANHYDROUS 200 ug/5mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsLEVOTHYROXINE SODIUM ANHYDROUS 200 ug/5mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsLEVOTHYROXINE SODIUM ANHYDROUS 100 ug/5mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsLEVOTHYROXINE SODIUM ANHYDROUS 500 ug/5mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Levothyroxine Sodium — NDC 42023-0202-01," retrieved September 3, 2026, https://drugdashboards.com/drug/42023020201.

Free to cite with attribution — see how the data is put together.